	Inflammatory Memory in Psoriasis: From Remission to Recurrence. J Allergy Clin Immunol Francis L, Capon F, Smith CH, Haniffa M, Mahil SK. PMID: 38761994 [PubMed - as supplied by publisher]
	Study of lncRNAs expression profile in the response to biological drugs in Psoriatic Arthritis: MEG3 could be a potential genomic biomarker of therapy efficacy. Int Immunopharmacol De Benedittis G, D'Antonio A, Latini A, Morgante C, Conigliaro P, Triggianese P, Bergamini A, Novelli G, Ciccacci C, Chimenti MS, Borgiani P. PMID: 38761785 [PubMed - as supplied by publisher]
	Association between lipid accumulation product and psoriasis among adults: a nationally representative cross-sectional study. Lipids Health Dis Zhang C, Dong X, Chen J, Liu F. PMID: 38760661 [PubMed - indexed for MEDLINE]
	Comment on: Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel. Rheumatology (Oxford) Zervou MI, Goulielmos GN. PMID: 38759120 [PubMed - as supplied by publisher]
	Genomeâ€‘wide association study and polygenic risk scores predict psoriasis and its shared phenotypes in Taiwan. Mol Med Rep Yang JS, Liu TY, Lu HF, Tsai SC, Liao WL, Chiu YJ, Wang YW, Tsai FJ. PMID: 38757301 [PubMed - indexed for MEDLINE]
	Risk of Head and Neck Cancer in Patients with Psoriasis: A Nationwide Population-based Study. Acta Derm Venereol Huh G, Kim D, Lee KN, Han K, Cho JH. PMID: 38757177 [PubMed - indexed for MEDLINE]
	The Effect of JAK Inhibitors on Patient-Reported Outcomes in Psoriatic Arthritis. Mediterr J Rheumatol Tsiogkas SG, Perricone C, Bogdanos DP. PMID: 38756934 [PubMed]
	Spesolimab: A Review of the First IL-36 Blocker Approved for Generalized Pustular Psoriasis. Ann Pharmacother Pathak GN, Wang E, Dhillon J, Parikh PN, Esseghir R, Rao BK, Feldman SR. PMID: 38755971 [PubMed - as supplied by publisher]
	Effect of Bimekizumab on Patient-Reported Disease Impact in Patients with Psoriatic Arthritis: 1-Year Results from Two Phase 3 Studies. Rheumatology (Oxford) Gossec L, Orbai AM, de Wit M, Coates LC, Ogdie A, Ink B, Coarse J, Lambert J, Taieb V, Gladman DD. PMID: 38754125 [PubMed - as supplied by publisher]
	Correction: Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1). Rheumatol Ther Kameda H, Hagimori K, Morisaki Y, Holzkämper T, Konomi A, Dobashi H. PMID: 38753272 [PubMed - as supplied by publisher]
	Deep cardiac phenotyping by cardiovascular magnetic resonance reveals subclinical focal and diffuse myocardial injury in patients with psoriasis (PSOR-COR study). Clin Res Cardiol Gröschel J, Grassow L, Blaszczyk E, Lommel K, Kokolakis G, Sabat R, Schulz-Menger J. PMID: 38753001 [PubMed - as supplied by publisher]
	Calcipotriol Nanosuspension-Loaded Trilayer Dissolving Microneedle Patches for the Treatment of Psoriasis: In Vitro Delivery and In Vivo Antipsoriatic Activity Studies. Mol Pharm Dai X, Permana AD, Li M, Habibie, Nur Amir M, Peng K, Zhang C, Dai H, Paredes AJ, Vora LK, Donnelly RF. PMID: 38752564 [PubMed - as supplied by publisher]
	Unveiling metabolic similarities of entheses in psoriasis and psoriatic arthritis patients using non-invasive in vivo imaging - results from the MAPSA study. Arthritis Rheumatol Fagni F, Tascilar K, Noversa de Sousa R, Bayat S, Sollfrank L, Kleyer A, Sticherling M, Regensburger AP, Knieling F, Neurath MF, Schett G, Waldner M, Simon D. PMID: 38751108 [PubMed - as supplied by publisher]
	Single-cell technologies in psoriasis. Clin Immunol Cui N, Xu X, Zhou F. PMID: 38750947 [PubMed - as supplied by publisher]
	Managing the Patient with Psoriasis and Metabolic Comorbidities. Am J Clin Dermatol Bellinato F, Maurelli M, Geat D, Girolomoni G, Gisondi P. PMID: 38748391 [PubMed - as supplied by publisher]
	Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis). Dermatol Ther (Heidelb) Valenti M, Gargiulo L, Ibba L, Malagoli P, Amoruso F, Balato A, Bardazzi F, Burlando M, Carrera CG, Dapavo P, Dini V, Gaiani FM, Girolomoni G, Guarneri C, Lasagni C, Loconsole F, Marzano AV, Maurelli M, Megna M, Orsini D, Travaglini M, Costanzo A, Narcisi A. PMID: 38748344 [PubMed - as supplied by publisher]
	Comparative analysis of persistence and remission with guselkumab versus secukinumab and ixekizumab in the United States. J Dermatolog Treat Zhdanava M, Fitzgerald T, Pilon D, Teneralli RE, Shah A, Diaz L, Lefebvre P, Feldman SR. PMID: 38747375 [PubMed - indexed for MEDLINE]
	Safety and effectiveness of guselkumab in Japanese patients with psoriasis: 20-week interim analysis of a postmarketing surveillance study. J Dermatol Tada Y, Sugiura Y, Kamishima M, Tanaka Y, Tsuchiya H, Masuda J, Yamanaka K. PMID: 38747075 [PubMed - as supplied by publisher]
	Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review. Vasc Health Risk Manag Mehta H, Narang T, Dogra S, Handa S, Hatwal J, Batta A. PMID: 38745849 [PubMed - indexed for MEDLINE]
	Roles of negative emotions and personality traits in psoriasis vulgaris: A mendelian randomization study. Skin Res Technol Zhang M, Hu Y, Chen L, Chen H, Huang D, Luan C, Zhang J, Chen K. PMID: 38743386 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 24353

Page 1 of 1218



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy